Innoviva Inc (INVA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.31B
Last updated: Nov 17, 2026 at 4:15 PM ET
Innoviva Inc (INVA) Statistics
Innoviva (INVA) has a market cap of $1.31B and an enterprise value of $991.73M. It kept 44.13% of revenue as net income over the last 12 months. Its trailing P/E of 5.2x is below its 10-year median of 9.1x.
Total Valuation
Enterprise value is 24.54% below the market cap, as cash exceeds debt.
| Market Cap | $1.31B |
|---|---|
| Enterprise Value | $991.73M |
| Latest price (Nov 17, 2026) | $18.30 |
Key Dates
The next earnings report is expected on Feb 23, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 23, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 3.0x and 1.2x. Its year-end P/E ranged from 6.2x to 59.8x from 2016 to 2025.
| P/E Ratio | 5.2x |
|---|---|
| Forward P/E | 12.3x |
| P/S Ratio | 3.0x |
| Forward P/S | 3.0x |
| P/B Ratio | 1.2x |
| P/TBV Ratio | 1.4x |
| P/FCF Ratio | 7.2x |
| P/OCF Ratio | 7.2x |
| PEG Ratio | 0.4 |
Enterprise Valuation
Counting debt and cash, the company is valued at 4.6x EBITDA and 5.5x free cash flow.
| EV / Earnings | 5.1x |
|---|---|
| EV / Sales | 2.3x |
| EV / EBITDA | 4.6x |
| EV / FCF | 5.5x |
Price Statistics
The stock is down 17.75% over 52 weeks and trades 11.08% below its 50-day average.
| Beta (1Y) | 0.34 |
|---|---|
| 52-Week Change | -17.75% |
| 1-Month Change | -13.19% |
| 3-Month Change | -14.80% |
| 6-Month Change | -15.78% |
| 5-Year Change | +21.60% |
| 10-Year Change | +106.02% |
| Total Return (1Y) | -17.75% |
| Total Return (3Y CAGR) | +10.08% |
| Total Return (5Y CAGR) | +1.33% |
| Return vs SPY (1Y) | -27.88% |
| Max Drawdown (1Y) | -24.50% |
| Max Drawdown (3Y) | -24.50% |
| Sharpe Ratio (1Y) | -0.70 |
| Correlation with SPY (1Y) | 0.18 |
| 50-Day Average | $20.58 |
| 200-Day Average | $21.87 |
| 52-Week Range | $18.41 to $25.15 |
| RSI (14 Days) | 27.3 |
| Average Volume (20 Days) | 897.36K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 15.44x current liabilities, and total debt is 0.23x shareholder equity.
| Current Ratio | 15.44x |
|---|---|
| Quick Ratio | 14.58x |
| Debt / Equity | 0.23x |
| Debt / EBITDA | 1.20x |
| Debt / FCF | 1.42x |
| Interest Coverage | 8.85x |
Returns and Efficiency
Return on invested capital is 10.78% over the last 12 months, against a 5-year average of 19.14%.
| Return on Equity (ROE) | 17.01% |
|---|---|
| Return on Assets (ROA) | 12.58% |
| Return on Invested Capital (ROIC) | 10.78% |
| ROE (5Y Average) | 36.20% |
| ROA (5Y Average) | 18.11% |
| ROIC (5Y Average) | 19.14% |
| Asset Turnover | 0.30x |
| Inventory Turnover | 2.73x |
| Receivables Turnover | 9.24x |
| Cash Conversion Cycle | 156 days |
Taxes
Income tax took 13.63% of pretax income over the last 12 months.
| Income Tax (TTM) | $30.53M |
|---|---|
| Effective Tax Rate | 13.63% |
Scores
INVA has an Altman Z-Score of 3.47, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 3.47 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $438.32M over the last 12 months is up 12.82% from the 12 months before.
| Revenue | $438.32M |
|---|---|
| Revenue Growth (YoY) | +12.82% |
| Gross Profit | $326.50M |
| Operating Income | $170.15M |
| Pretax Income | $223.97M |
| Net Income | $193.44M |
| Reported EPS (TTM) | $3.50 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 74.03% of the $1.54B in total assets.
| Cash and Equivalents | $581.39M |
|---|---|
| Total Debt | $258.82M |
| Net Cash | $322.57M |
| Net Cash Per Share | $4.48 |
| Working Capital | $722.22M |
| Shareholder Equity | $1.14B |
| Book Value Per Share | $15.78 |
| Tangible Book Value | $957.34M |
| Tangible Book Per Share | $13.28 |
| Total Assets | $1.54B |
| Total Liabilities | $400.41M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $955.00K of capital spending, operating cash flow left $182.51M of free cash flow.
| Operating Cash Flow | $183.47M |
|---|---|
| Capital Expenditures | $955.00K |
| Free Cash Flow | $182.51M |
| FCF Per Share | $2.53 |
| Depreciation and Amortization | $41.99M |
| Share Repurchases | $81.92M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 38.82%, against a 5-year average of 67.73%.
| Gross Margin | 74.49% |
|---|---|
| Operating Margin | 38.82% |
| Pretax Margin | 51.10% |
| Net Margin | 44.13% |
| FCF Margin | 41.64% |
| Gross Margin (5Y Average) | 86.49% |
| Operating Margin (5Y Average) | 67.73% |
| Net Margin (5Y Average) | 58.19% |
Growth
Revenue grew 7.47% a year over 3 years, and EPS 70.09% a year.
| Revenue Growth (3Y CAGR) | +7.47% |
|---|---|
| Revenue Growth (5Y CAGR) | +4.08% |
| EPS Growth (3Y CAGR) | +70.09% |
| EPS Growth (5Y CAGR) | +11.63% |
| FCF Growth (3Y CAGR) | -0.98% |
| FCF Growth (5Y CAGR) | -8.96% |
| Operating Income Growth (3Y CAGR) | -20.05% |
| Book Value Per Share Growth (2Y CAGR) | +31.61% |
| Tangible Book Per Share Growth (2Y CAGR) | +50.75% |
Dividends and Yields
INVA does not pay a dividend. Its free cash flow yield is 13.84%.
| Earnings Yield | 19.23% |
|---|---|
| FCF Yield | 13.84% |
| Buyback Yield | 5.93% |
| Shareholder Yield | 5.93% |
Peer Position
Against 9 similar companies, INVA has the 9th highest P/S.
P/S RatioPeer median 8.4x
ROICPeer median -66.62%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +13.52%
| P/S Ratio | 3.0x vs 8.4x median |
|---|---|
| ROIC | 10.78% vs -66.62% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +12.82% vs +13.52% median |
Analyst Forecast
Consensus estimates put revenue growth at 7.50% and EPS growth at -16.21% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +7.50% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | -16.21% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About INVA
What is INVA's market cap?
Innoviva has a market cap of $1.31B. Its enterprise value, which adds debt and subtracts cash, is $991.73M.
What is INVA's P/E ratio?
Innoviva has a trailing P/E ratio of 5.2x and a forward P/E of 12.3x.
How many shares of INVA are outstanding?
Innoviva has 72.07M shares outstanding. The count is up 4.36% from a year earlier.
Does INVA pay a dividend?
No. Innoviva does not pay a dividend.
How much debt does INVA have?
Innoviva has $258.82M of total debt and $581.39M of cash and equivalents, a net cash position of $322.57M.
INVA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors